Gilead Sciences
GILD
#94
Rank
C$245.55 B
Marketcap
C$197.80
Share price
-0.56%
Change (1 day)
24.13%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.14

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$8.93. In 2024 the company made an earnings per share (EPS) of C$0.52 a decrease over its 2023 EPS that were of C$6.23.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.141655.67%
2024C$0.52-91.65%
2023C$6.2323.98%
2022C$5.03-25.86%
2021C$6.784850%
2020C$0.14-97.64%
2019C$5.810.9%
2018C$5.7618.71%
2017C$4.85-64.88%
2016C$13.81-18.45%
2015C$16.9355.28%
2014C$10.90296.02%
2013C$2.7517.89%
2012C$2.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.26 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.86-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$3.28-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.53 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.63 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.05 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$6.12-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$19.63 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.01 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA